Improved blood safety measures from Pall can increase platelet availability

October 17, 2005

East Hills, New York (Oct. 17, 2005) - - Availability of safe platelets is a fundamental blood transfusion challenge and can be especially problematic in times of emergency. Several studies presented at the annual AABB meeting today demonstrate new approaches to counteract platelet shortages by enhancing the safety of whole blood derived platelets, precluding the need to rely on only those obtained through apheresis.

"If platelets from whole blood are tested for bacteria using state-of-the-art culture detection methods, the risk of transfusing contaminated platelets would be significantly reduced and transfusion medicine specialists would no longer have to make a trade-off between clinical safety and availability," says Stein Holme, Ph.D., vice president, R&D Applications, Pall Corporation (NYSE: PLL), one of the presenters at AABB. Bacterial contamination of platelets is the leading infectious cause of sickness and death from a blood transfusion.

Dr. Holme explains that there is currently a disparity in platelet safety. Apheresis (single donor) platelets, which are time-consuming and expensive to obtain, are tested for bacterial contamination using the most sensitive culture detection methods. Whereas whole blood derived platelets are typically tested using less sensitive and reliable methods such as dipsticks or pH meters. Hospitals resort to these less sensitive methods since whole blood derived platelets need to be individually sampled for bacterial contamination (five separate tests) prior to pooling into a standard therapeutic dose for transfusion. However, if whole blood derived platelets were first pooled and then tested for bacteria using a more sensitive detection method, only one testing sample would be required. This approach would increase the safety standard of transfused platelets and ensure that this valuable resource is more readily available. It would also be more cost-effective, as it would reduce the handling costs of hospitals.

Dr. Holme provided an overview of the results from a series of studies conducted by research institutions in the U.S. and Canada that demonstrate the value of prestoraged pooled platelets. In vivo studies showed that prestoraged pooled platelets have an equivalent clinical response (the number of platelets that continue to circulate in the human body post-transfusion) to platelets pooled at the time of transfusion. The pooled and stored platelets also showed equivalent quality based on standard quality criteria and measures.

Steven Young, Ph.D., Scientific Director Microbiology & Virology, Tricore Reference Laboratories, presented a study on bacteria detection of pooled platelet concentrates, which evaluated the ability of the Pall eBDS System to detect 10 different bacteria that can contaminate platelets. The results of this study found that the Pall eBDS System, one of the most sensitive culture methods, was effective in detecting bacteria (greater than 99 percent) in pooled platelets.

Dr. Young concludes, "The ability to store random donor platelets concentrates as a pool would provide significant benefits such as having a therapeutic dose ready in emergency situations, reducing pool outdating, and enabling a simplified method for bacteria detection."

This month Pall Corporation was granted FDA clearance to market the Pall AcrodoseTM PL System, which provides a therapeutic dose of leukoreduced platelets that are tested for bacteria contamination with the integrated Pall eBDS technology. The new system enables blood centers to pool whole blood derived platelets and conduct a single state-of-the-art bacterial contamination test to enhance platelet safety and availability. The resulting AcrodoseSM Platelets are transfusion-ready and reduce the cost burden to hospitals by eliminating the need for further processing and testing.

Adding to this body of knowledge, Joseph D. Sweeny, M.D., Medical Director Blood Bank, Miriam Hospital, and Associate Professor of Medicine, Brown University in Providence, Rhode Island, presented the results of a study on extending the shelf life of platelets from 5 days to 7 days. Platelets outdate and are disposed of in about five days. This study examined the logistics and storage properties of whole blood derived pooled platelets stored in additive solution. The study showed that there was good in vitro function and preservation of the platelets to day seven based on all measures studied, with white blood cell counts and platelet yield similar to apheresis products.

There are currently about 2.1 million platelet transfusions in the U.S. annually. Platelets are the blood component responsible for blood clotting functions, and are typically diminished in patients undergoing chemotherapy, treatments related to organ transplant or victims of severe burns. They are essential blood products in times of emergency such as radiation exposure during an environmental or WMD event to a major disease outbreak, such as the recent events in Calcutta, India, which resulted in severe platelet shortage due to a simultaneous outbreak of multiple diseases (dengue hemorrhagic fever, malaria and typhoid).
-end-
About Pall Corporation
Pall Corporation is the global leader in the rapidly growing field of filtration, separations and purification. Pall's business is organized around two broad markets: Life Sciences and Industrial. The Company provides leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceutical, transfusion medicine, semiconductor, water purification, aerospace and broad industrial markets. Total revenues for fiscal 2005 were $1.9 billion. The Company headquarters is in East Hills, New York with extensive operations throughout the world. Visit Pall at http://www.pall.com/.

Editors Notes:

  • Photos and additional information can be found on http://www.pall.com/corporate_38334.asp
  • Visit Pall at AABB Booth #301, Washington State Convention & Trade Center, Seattle, Oct.15-18
  • The studies noted in the above press release are:

    New Platform for Platelet Transfusion Safety: Workshop: Pre-storage pooling of whole-blood derived platelets with new Pall AcrodoseTM PL System. Speakers representing University of Cincinnati Medical Center, American Red Cross Penn Jersey Division, University of Michigan Transfusion Medicine, Oct. 16, 12:15 p.m., Room 615-617.

    Detection of Bacteria in Pooled Platelet Concentrates Using Pall eBDS: Oral presentation by Tricore Reference Laboratories, Albuquerque NM and Pall Medical, Oct. 18, 10:30 a.m.-noon, Room 613-614.

    Media Contact:
    Marcia Katz
    Pall Corporation
    Tel: (516) 801-9128
    E-mail: Marcia_Katz@Pall.com

    Pall Corporation

    Related Bacteria Articles from Brightsurf:

    Siblings can also differ from one another in bacteria
    A research team from the University of Tübingen and the German Center for Infection Research (DZIF) is investigating how pathogens influence the immune response of their host with genetic variation.

    How bacteria fertilize soya
    Soya and clover have their very own fertiliser factories in their roots, where bacteria manufacture ammonium, which is crucial for plant growth.

    Bacteria might help other bacteria to tolerate antibiotics better
    A new paper by the Dynamical Systems Biology lab at UPF shows that the response by bacteria to antibiotics may depend on other species of bacteria they live with, in such a way that some bacteria may make others more tolerant to antibiotics.

    Two-faced bacteria
    The gut microbiome, which is a collection of numerous beneficial bacteria species, is key to our overall well-being and good health.

    Microcensus in bacteria
    Bacillus subtilis can determine proportions of different groups within a mixed population.

    Right beneath the skin we all have the same bacteria
    In the dermis skin layer, the same bacteria are found across age and gender.

    Bacteria must be 'stressed out' to divide
    Bacterial cell division is controlled by both enzymatic activity and mechanical forces, which work together to control its timing and location, a new study from EPFL finds.

    How bees live with bacteria
    More than 90 percent of all bee species are not organized in colonies, but fight their way through life alone.

    The bacteria building your baby
    Australian researchers have laid to rest a longstanding controversy: is the womb sterile?

    Hopping bacteria
    Scientists have long known that key models of bacterial movement in real-world conditions are flawed.

    Read More: Bacteria News and Bacteria Current Events
  • Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.